S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion

Study overview

The Purpose of the study is to test the hypothesis that administration of an S-nitrosylating (SNO) agent can improve tissue oxygenation during transfusion of packed red blood cells (RBCs).

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

James Reynolds,

Mada Helou, MD, PRINCIPAL_INVESTIGATOR, University Hospitals Cleveland Medical Center

Batuhan Degis, MD, STUDY_DIRECTOR, Case Western Reserve University

Study Record Dates

2028-02-29